PIK3CA Amplified Advanced Solid Tumors
1 clinical trials · Condition
◉ Watch PIK3CA Amplified Advanced Solid Tumors
| Record | Firm | Date |
|---|---|---|
| A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors (NCT01708161) | Novartis Pharmaceuticals | 2012-11-27 |
Track PIK3CA Amplified Advanced Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.